Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-15 09:30 am Sale | 2022-12-12 | 13D | Surrozen, Inc. SRZN | Consonance Capital Management LP | 0 0.000% | -446,200 (Position Closed) | Filing History |
| 2022-02-14 2:45 pm Sale | 2021-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 0 0.000% | -164,156 (Position Closed) | Filing History |
| 2022-02-14 1:58 pm Sale | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Consonance Capital Management LP | 0 0.000% | -15,678 (Position Closed) | Filing History |
| 2022-02-14 1:57 pm Sale | 2021-12-31 | 13G | Sio Gene Therapies Inc. SIOX | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | Filing History |
| 2022-02-14 1:57 pm Sale | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Consonance Capital Management LP | 0 0.000% | -2,729,709 (Position Closed) | Filing History |
| 2022-02-14 1:56 pm Sale | 2021-12-31 | 13G | GENMARK DIAGNOSTICS INC GNMK | Consonance Capital Management LP | 0 0.000% | -4,480,163 (Position Closed) | Filing History |
| 2022-02-14 1:56 pm Sale | 2021-12-31 | 13G | GAMIDA CELL LTD GMDAQ | Consonance Capital Management LP | 0 0.000% | -3,287,745 (Position Closed) | Filing History |
| 2022-02-14 1:55 pm Sale | 2021-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI | Consonance Capital Management LP | 0 0.000% | -757,643 (Position Closed) | Filing History |
| 2022-02-14 1:52 pm Unchanged | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | Consonance Capital Management LP | 1,558,290 1.650% | 0 (Unchanged) | Filing History |
| 2021-09-29 11:10 am Purchase | 2021-09-24 | 13D | Surrozen, Inc. SRZN | Consonance Capital Management LP | 446,200 18.400% | 87,367 (+24.35%) | Filing History |
| 2021-08-18 3:33 pm Purchase | 2021-08-11 | 13D | Surrozen, Inc. SRZN | Consonance Capital Management LP | 358,833 15.400% | 358,833 (New Position) | Filing History |
| 2021-04-27 3:34 pm Purchase | 2021-04-15 | 13D | CONSONANCE-HFW ACQUISITION COR CHFW | Consonance Capital Management LP | 1,434,000 14.900% | 1,434,000 (New Position) | Filing History |